Trial Profile
Neuropsychological assessment of efficacy of atomoxetine in attention deficit hyperactivity disorder [EVALUACION NEUROPSICOLOGICA DE LA EFICACIA DE LA ATOMOXETINA EN EL TRASTORNO POR DEFICIT DE ATENCION CON HIPERACTIVIDAD]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2011
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder; Hyperactivity
- Focus Therapeutic Use
- 28 Jun 2011 New trial record